During the past decade, P-one clinic conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 2 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "P-one clinic" #1 sponsor was "Pfizer" with 9 trials, followed by "Eli Lilly and Company" with 8 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Mochida Pharmaceutical Company, Ltd." with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "P-one clinic" #1 collaborator was "Fuji Yakuhin Co., Ltd." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "P-one clinic" are "Healthy" (10 trials), "Alzheimer Disease" (4 trials), "Diabetes Mellitus, Type 2" (4 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Healthy Volunteers" (1 trials). Many other conditions were trialed in "P-one clinic" in a lesser frequency.

Most popular intervention types in "P-one clinic" are "Drug" (23 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Donanemab" (2 trials), "FYU-981" (2 trials), "Gantenerumab" (2 trials) and "LY3209590" (2 trials). Other intervention names were less common.

The vast majority of trials in "P-one clinic" are 22 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "P-one clinic". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in P-one clinic, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in P-one clinic, 19 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".